University of Hertfordshire

Dr Adam Young

Publications

  1. 2022
  2. The role of comorbidities alongside patient and disease characteristics on long-term disease activity in RA using UK inception cohort data

    Busby, A., Wason, J., Pratt, A., Young, A., Isaacs, J. & Nikiphorou, E., 22 Apr 2022.

    Research output: Contribution to conferencePaperpeer-review

  3. The association between social deprivation and disease activity in rheumatoid arthritis: A systematic literature review

    Dey, M., Busby, A., Ewell, H., Lempp, H., Pratt, A., Young, A., Isaacs, J. & Nikiphorou, E., 29 Mar 2022, (Accepted/In press) In: RMD Open.

    Research output: Contribution to journalArticlepeer-review

  4. The role of comorbidities alongside patient and disease characteristics on long-term disease activity in RA using UK inception cohort data

    Busby, A., Wason, J., Pratt, A., Young, A., Isaacs, J. & Nikiphorou, E., 8 Mar 2022, (E-pub ahead of print) In: Rheumatology.

    Research output: Contribution to journalArticlepeer-review

  5. 2021
  6. Large joints are progressively involved in rheumatoid arthritis irrespective of rheumatoid factor status—results from the early rheumatoid arthritis study

    Zhao, S. S., Nikiphorou, E., Young, A. & Kiely, P. D. W., 16 Aug 2021, In: Rheumatology International. 42, 4, p. 621-629 9 p.

    Research output: Contribution to journalArticlepeer-review

  7. Predictors of poor function in RA based on two prospective UK inception cohorts. Do comorbidities matter?

    Busby, A., Wason, J., Pratt, A., Young, A., Isaacs, J. & Nikiphorou, E., 24 Jul 2021, In: Rheumatology. 7 p., keab598.

    Research output: Contribution to journalArticlepeer-review

  8. The use and context of the term “multimorbidity” in rheumatoid arthritis: a systematic literature review

    Dey, M., Busby, A., Ewell, H., Pratt, A., Young, A., Isaacs, J. & Nikiphorou, E., 23 Apr 2021, In: Rheumatology. 14 p., keab214.

    Research output: Contribution to journalArticlepeer-review

  9. Entry in progress

    Treat-to-target strategies in rheumatoid arthritis: a systematic review & cost-effectiveness analysis.

    Young, A., 12 Jan 2021, (Accepted/In press) In: SN Comprehensive Clinical Medicine.

    Research output: Contribution to journalArticlepeer-review

  10. 2020
  11. Secular changes in the progression of clinical markers and patient-reported outcomes in early rheumatoid arthritis

    Carpenter, L., Nikiphorou, E., Kiely, P. D. W., Walsh, D. A., Young, A. & Norton, S., 3 Jan 2020, (E-pub ahead of print) In: Rheumatology. 11 p., kez635.

    Research output: Contribution to journalArticlepeer-review

  12. 2019
  13. Disease activity flares and pain flares in an early rheumatoid arthritis inception cohort; characteristics, antecedents and sequelae

    McWilliams, D. F., Rahman, S., James, R. J. E., Ferguson, E., Kiely, P. D. W., Young, A. & Walsh, D. A., 18 Nov 2019, In: BMC Rheumatology. 3, 1, p. 49

    Research output: Contribution to journalArticlepeer-review

  14. Remission vs low disease activity: function, quality of life and structural outcomes in the Early Rheumatoid Arthritis Study and Network

    Nikiphorou, E., Norton, S., Carpenter, L., Welsh, D., Creamer, P., Dixey, J., Young, A. & Kiely, P., 3 Oct 2019, In: Rheumatology. 59, 6, p. 1272–1280

    Research output: Contribution to journalArticlepeer-review

  15. Discrete trajectories of resolving and persistent pain in people with rheumatoid arthritis despite undergoing treatment for inflammation: Results from three UK cohorts.

    McWilliams, D. F., Dawson, O., Young, K., Kiely, P., Ferguson, E. & Walsh, D., 1 Jun 2019, In: The Journal of Pain. 20, 6, p. 716-727 12 p.

    Research output: Contribution to journalArticlepeer-review

  16. Not all moderate disease is the same - Identification of disability trajectories among patients with rheumatoid arthritis and moderate disease activity

    Pan, Y., Norton, S., Gwinnutt, J. M., Kearsley-Fleet, L., Symmons, D. P. M., Lunt, M., Young, A., Hyrich, K. L. & Verstappen, S. M. M., 20 May 2019, In: PLoS ONE. 14, 5, e0215999.

    Research output: Contribution to journalArticlepeer-review

  17. Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts

    Kiely, P., Busby, A., Nikiphorou, E., Sullivan, K., Walsh, D., Creamer, P., Dixey, J. & Young, K., 5 May 2019, In: BMJ Open. 9, 5, e028466.

    Research output: Contribution to journalArticlepeer-review

  18. 2018
  19. Sarilumab for Previously-Treated Moderate or Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

    Bermejo, I., Ren, S., Simpson, E., Clowes, M., Scott, D. L., Young, K. & Stevenson, M., 1 Dec 2018, In: Pharmacoeconomics. 36, 12, p. 1427-1437 10 p.

    Research output: Contribution to journalArticlepeer-review

  20. Validation of methods for converting the original Disease Activity Score (DAS) to the DAS28

    Carpenter, L., Norton, S., Nikiphorou, E., Kiely, P., Walsh, D., Dixey, J. & Young, K., 1 Dec 2018, In: Rheumatology International. 38, 12, p. 2297-2305 8 p.

    Research output: Contribution to journalArticlepeer-review

  21. Tofacitinib for Treating Rheumatoid Arthritis After the Failure of Disease-Modifying Anti-rheumatic Drugs: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

    Uttley, L., Bermejo, I., Ren, S., Martyn-St James, M., Wong, R., Scott, D. L., Stevenson, M. & Young, K., 1 Sep 2018, In: Pharmacoeconomics. 36, 9, p. 1063-1072 10 p.

    Research output: Contribution to journalArticlepeer-review

  22. Baricitinib for previously treated moderate or severe rheumatoid arthritis: An Evidence Review Group perspective of a NICE Single Technology Appraisal

    Ren, S., Bermejo, I., Simpson, E. L., Wong, R., Scott, D., Young, K. & Stevenson, M. D., 1 Jul 2018, In: Pharmacoeconomics. 36, 7, p. 769-778 10 p.

    Research output: Contribution to journalArticlepeer-review

  23. The Association of Obesity with Adverse Disease Activity, Functional Ability and Quality of Life In Early Rheumatoid Arthritis: data from the Early Rheumatoid Arthritis Study/Early Rheumatoid Arthritis Network UK prospective cohorts

    Nikiphorou, E., Norton, S., Young, K., Dixey, J., Walsh, D., Helliwell, H. & Kiely, P., 1 Jul 2018, In: Rheumatology. 57, 7, p. 1194-1202 9 p.

    Research output: Contribution to journalArticlepeer-review

  24. Interpretation of DAS28 and its components in the assessment of inflammatory and non-inflammatory aspects of rheumatoid arthritis

    Young, K., McWilliams, D. F., Kiely, P., Joharatnam, N., Wilson, D. & Walsh, D., 23 Mar 2018, In: BMC Rheumatology. 2, p. 1-12 12 p., 8.

    Research output: Contribution to journalArticlepeer-review

  25. 2017
  26. The clinical effectiveness and cost-effectiveness of treat-to-target strategies in rheumatoid arthritis: a systematic review and cost-effectiveness analysis

    Wailoo, A., Hock, E. S., Stevenson, M., Martyn-St James, M., Rawdin, A., Simpson, E., Wong, R., Dracup, N., Scott, D. L. & Young, A., 1 Dec 2017, 71 ed. National Institute for Health Research (NIHR). 258 p. (Health Technology Assessment)

    Research output: Book/ReportOther report

  27. Reductions in Radiographic Progression in Early Rheumatoid Arthritis Over Twenty-Five Years: Changing Contribution From Rheumatoid Factor in Two Multicenter UK Inception Cohorts

    Carpenter, L., Norton, S., Nikiphorou, E., Jayakumar, K., McWilliams, D. F., Rennie, K. L., Dixey, J., Kiely, P., Walsh, D. A., Young, A. & on behalf of the Early Rheumatoid Arthritis Study and the Early Rheumatoid Arthritis Network, 28 Nov 2017, In: Arthritis Care and Research. 69, 12, p. 1809-1817 9 p.

    Research output: Contribution to journalArticlepeer-review

  28. Certolizumab Pegol for Treating Rheumatoid Arthritis Following Inadequate Response to a TNF-α Inhibitor: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

    Bermejo, I., Stevenson, M., Archer, R., Stevens, J. W., Goka, E., Clowes, M., Scott, D. L. & Young, A., 1 Nov 2017, In: Pharmacoeconomics. 35, 11, p. 1141-1151 11 p.

    Research output: Contribution to journalReview articlepeer-review

  29. Predicting responses in patients with rheumatoid arthritis to disease-modifying agents using baseline clinical data

    Gullick, N. J., Mian, A. N., Ibrahim, F., Walker, D., Hassell, A., Kiely, P. D. W., Walsh, D. A., Young, A., Scott, D. L., Lempp, H., Sturt, J., Georgopoulou, S., Prothero, L., Martin, N., Jenner, R., Neatrour, I., Baggott, R., Wailoo, A., Tosh, J., Galloway, J. & 6 others, Kingsley, G., Scott, D., Tom, B., Zhong, Y., Mian, A. & on behalf of TITRATE Programme Investigators, 15 Sep 2017, In: Clinical and Experimental Rheumatology. 35, 5, p. 810-815 6 p.

    Research output: Contribution to journalArticlepeer-review

  30. The Cost-effectiveness of Sequences of Biological Disease-modifying Antirheumatic Drug Treatment in England for Patients with Rheumatoid Arthritis Who Can Tolerate Methotrexate

    Stevenson, M. D., Wailoo, A. J., Tosh, J. C., Hernandez-Alava, M., Gibson, L. A., Stevens, J. W., Archer, R. J., Simpson, E. L., Hock, E. S., Young, A. & Scott, D. L., 1 Jul 2017, In: Journal of Rheumatology. 44, 7, p. 973-980 8 p.

    Research output: Contribution to journalArticlepeer-review

  31. Achieving consensus on minimum data items (including core outcome domains) for a longitudinal observational cohort study in rheumatoid arthritis

    Nikiphorou, E., Mackie, S. L., Kirwan, J., Boers, M., Isaacs, J., Morgan, A. W. & Young, A., 1 Apr 2017, In: Rheumatology (United Kingdom). 56, 4, p. 550-555 6 p.

    Research output: Contribution to journalArticlepeer-review

Previous 1 2 3 Next